what are glp 1 agonists Current Insights, Advantages and Challenges of Small Molecule Glucagon-like Peptide Receptor Agonists: A Scoping Review Recent updates on GLP-1 agonists:
Description
Lancet 372, 12401250
Site-specific pegylated Exendin-4 modified with a high molecular weight trimeric PEG reduces steric hindrance and increases type 2 antidiabetic therapeutic effects
After 36 weeks, retatrutide resulted in HbA1c reduction up to 2.2% vs
The only problem: the effects dont last very long
